Table 4.
Demographic characteristics of 329 patients who treated with statin derivations who did not get to target LDL.
| Framingham risk variable | Risk category (not get to target LDL) | ||||
|---|---|---|---|---|---|
| extreme risk (n = 9) | Very high risk (n = 242) | High risk (n = 16) | Moderate risk (n = 62) | P value | |
| Age | 73.88 ± 10.75 | 66.90 ± 9.39 | 63.44 ± 8.59 | 56.84 ± 7.85*+ | < 0.001 |
| Female | 9 (100%) | 186 (76.9%) | 4 (25%) | 52 (83.9%) | < 0.001 |
| FBS | 138.63 ± 52.86 | 128.45 ± 48.11 | 106.25 ± 11.7 | 100.32 ± 14.52+ | < 0.001 |
| Cr | 0.95 ± 0.18 | 1.05 ± 0.55 | 0.92 ± 0.24 | 0.85 ± 0.16+ | 0.001 |
| GFR | 55.02 ± 29.84 | 66.22 ± 29. 37 | 86.91 ± 19.9+ | 90.97 ± 21.67*+ | < 0.001 |
| BMI | 29.36 ± 4.31 | 28.66 ± 5.36 | 29 ± 4.34 | 30.72 ± 4.25+ | 0.014 |
| WC | 97.63 ± 11.48 | 99.32 ± 10.6 | 100.81 ± 7.08 | 102.74 ± 7.67+ | 0.047 |
| Smoker | 1 (11.1) | 4 (1.7) | 0 | 0 | 0.180 |
| SBP | 141.25 ± 19.78 | 135.13 ± 15.98 | 134.38 ± 16.92 | 129.83 ± 15 | 0.071 |
| DBP | 80 ± 10.69 | 79.19 ± 10.14 | 83.75 ± 12.04 | 80 ± 8.07 | 0.399 |
*Exterme risk versus other groups.
+Very high versus other groups.
#High versus other groups.